Drug Shortage Report for AURO-ONDANSETRON INJECTION

Last updated on 2025-02-19 History
Report ID 235116
Drug Identification Number 02491524
Brand name AURO-ONDANSETRON INJECTION
Common or Proper name AURO-ONDANSETRON INJECTION
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ONDANSETRON
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 2ml vila x10
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-08-12
Estimated end date Unknown
Actual end date 2025-02-18
Shortage status Resolved
Updated date 2025-02-19
Company comments Please be informed that AURO-ONDANSETRON INJECTION ia available the Eugia label, DIN:02544822
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-02-19 French Compare
v7 2025-02-19 English Compare
v6 2024-09-24 French Compare
v5 2024-09-24 English Compare
v4 2024-08-13 English Compare
v3 2024-08-12 French Compare
v2 2024-08-12 English Compare
v1 2024-08-12 English Compare

Showing 1 to 8 of 8